<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>INOVIO PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Sun, 21 Jun 2026 05:15:14 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/inovio%5Fpharmaceuticals%5F1%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>INOVIO PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO</title><pubDate>Thu, 08 Jan 2026 16:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-inovio-pharmaceuticals-inc-ino-15402701</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">NEW YORK, <span class="legendSpanClass"><span class="xn-chron">Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-inovio-pharmaceuticals-inc-ino-15402701</guid></item><item><title>FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)</title><pubDate>Mon, 29 Dec 2025 14:05:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/fda-accepts-for-review-inovio-s-bla-for-ino-3107-for-the-treatment-of-adults-with-recurrent-respiratory-papillomatosis-rrp-15382750</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">PLYMOUTH MEETING, Pa., <span class="legendSpanClass"><span class="xn-chron">Dec. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/fda-accepts-for-review-inovio-s-bla-for-ino-3107-for-the-treatment-of-adults-with-recurrent-respiratory-papillomatosis-rrp-15382750</guid></item></channel></rss>
